Medical Properties Trust (MPW)
(Delayed Data from NYSE)
$4.51 USD
-0.03 (-0.66%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $4.53 +0.02 (0.44%) 7:58 PM ET
1-Strong Buy of 5 1
B Value F Growth B Momentum D VGM
Medical Properties (MPW) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$4.89 | $7.00 | $3.50 | 7.71% |
Price Target
Based on short-term price targets offered by nine analysts, the average price target for Medical Properties comes to $4.89. The forecasts range from a low of $3.50 to a high of $7.00. The average price target represents an increase of 7.71% from the last closing price of $4.54.
Analyst Price Targets (9 )
Broker Rating
Medical Properties currently has an average brokerage recommendation (ABR) of 3.58 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 12 brokerage firms. The current ABR compares to an ABR of 3.58 a month ago based on 12 recommendations.
Broker Rating Breakdown
![Broker Rating Visualization](https://widget3.zacks.com/images/charts/bar/brokerage/bar/MPW.png)
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 0 | 0 | 0 | 1 | 1 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 8 | 8 | 8 | 7 | 7 |
Sell | 1 | 1 | 1 | 1 | 1 |
Strong Sell | 3 | 3 | 3 | 3 | 3 |
ABR | 3.58 | 3.58 | 3.58 | 3.42 | 3.42 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
8/9/2024 | Truist Securities | Michael Lewis | Hold | Hold |
7/2/2024 | Exane BNP Paribas | Nathan D Crossett | Strong Buy | Hold |
6/17/2024 | Mizuho SecuritiesUSA | Vikram Malhotra | Hold | Hold |
5/14/2024 | Not Identified | Not Identified | Moderate Buy | Hold |
5/7/2024 | Wells Fargo Securities | Connor Siversky | Strong Sell | Strong Sell |
4/10/2024 | Colliers Securities | Barry Oxford | Moderate Buy | Hold |
2/29/2024 | Not Identified | Not Identified | Strong Sell | Strong Sell |
1/5/2024 | KeyBanc Capital Markets | Austin Wurschmidt | Strong Buy | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 3.58 |
ABR (Last week) | 3.58 |
# of Recs in ABR | 12 |
Average Target Price | $4.89 |
LT Growth Rate | 8.00% |
Industry | REIT and Equity Trust - Other |
Industry Rank by ABR | 96 of 253 |
Current Quarter EPS Est: | 0.22 |